ArticleThe Journal of clinical investigation2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Partow Kebriaei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
272 papers cite itlatest 60 shown
this paperpooled ittrialcites it